A detailed history of Aspire Private Capital, LLC transactions in Organon & Co. stock. As of the latest transaction made, Aspire Private Capital, LLC holds 91 shares of OGN stock, worth $1,405. This represents 0.0% of its overall portfolio holdings.

Number of Shares
91
Previous 91 -0.0%
Holding current value
$1,405
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

SELL
$13.78 - $18.8 $992 - $1,353
-72 Reduced 44.17%
91 $1,000
Q4 2023

Feb 01, 2024

SELL
$10.95 - $17.32 $54 - $86
-5 Reduced 2.98%
163 $2,000
Q3 2023

Nov 03, 2023

SELL
$16.59 - $23.77 $16 - $23
-1 Reduced 0.59%
168 $2,000
Q2 2023

Jul 24, 2023

SELL
$19.27 - $24.63 $134 - $172
-7 Reduced 3.98%
169 $3,000
Q1 2023

May 30, 2023

SELL
$21.42 - $32.08 $492 - $737
-23 Reduced 11.56%
176 $4,000
Q1 2023

May 03, 2023

SELL
$21.42 - $32.08 $492 - $737
-23 Reduced 11.56%
176 $4,000
Q4 2022

May 30, 2023

BUY
$23.31 - $28.61 $536 - $658
23 Added 13.07%
199 $5,000
Q4 2022

Feb 14, 2023

SELL
$23.31 - $28.61 $769 - $944
-33 Reduced 14.22%
199 $5,000
Q3 2022

Nov 10, 2022

SELL
$23.4 - $34.25 $117 - $171
-5 Reduced 2.11%
232 $5,000
Q2 2022

Aug 01, 2022

SELL
$31.66 - $38.9 $31 - $38
-1 Reduced 0.42%
237 $8,000
Q1 2022

May 10, 2022

SELL
$30.45 - $39.36 $822 - $1,062
-27 Reduced 10.19%
238 $8,000
Q4 2021

Feb 14, 2022

BUY
$28.67 - $37.13 $1,519 - $1,967
53 Added 25.0%
265 $8,000
Q3 2021

Nov 15, 2021

BUY
$28.63 - $35.64 $343 - $427
12 Added 6.0%
212 $7,000
Q2 2021

Aug 09, 2021

BUY
$28.45 - $38.0 $5,690 - $7,600
200 New
200 $6,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.93B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Aspire Private Capital, LLC Portfolio

Follow Aspire Private Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspire Private Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspire Private Capital, LLC with notifications on news.